Ignite Creation Date:
2024-05-06 @ 2:45 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04414800
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2020-05-22
Brief Title:
Intranasal Ketamine Versus Intranasal Fentanyl
Sponsor:
Isfahan University of Medical Sciences
Organization:
Isfahan University of Medical Sciences
Study Overview
Official Title:
Intranasal Ketamine Versus Intranasal Fentanyl on Pain Management in Isolated Traumatic Patients
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Abstract Background Given the inadequate control of pain in patients with injury that refer to the emergency departments the rapid onset of action of intranasal administration in pain management and the avoidance of administering opioid medications the present study aimed at evaluating the effect of intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients Materials and Methods The current study was performed on 125 patients that were divided into the following three groups control group n 41 1 mgkg intranasal ketamine group n 40 and 1μgkg intranasal fentanyl group n 44 Then pain scores HR RR BP and SaO2 were recorded at baseline 5 10 15 30 and 40 minutes after the intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None